Epidemiology of atrial fibrillation: European perspective

In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and...

Full description

Saved in:
Bibliographic Details
Published inClinical epidemiology Vol. 6; no. default; pp. 213 - 220
Main Authors Zoni-Berisso, Massimo, Lercari, Fabrizio, Carazza, Tiziana, Domenicucci, Stefano
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.01.2014
Taylor & Francis Ltd
Dove Medical Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications.
AbstractList In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%–0.16% of those younger than 49 years, in 3.7%–4.2% of those aged 60–70 years, and in 10%–17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14–17 million and the number of new cases of AF per year at 120,000–215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications.
In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications. Keywords: atrial fibrillation, epidemiology, risk factors, mortality, stroke
Massimo Zoni-Berisso, Fabrizio Lercari, Tiziana Carazza, Stefano DomenicucciDepartment of Cardiology, ASL 3, Padre A Micone Hospital, Genoa, ItalyAbstract: In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications.Keywords: atrial fibrillation, epidemiology, risk factors, mortality, stroke
In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications.In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care costs in western countries. The prevalence of AF is increasing due to our greater ability to treat chronic cardiac and noncardiac diseases, and the improved ability to suspect and diagnose AF. At the present time, the prevalence of AF (2%) is double that reported in the last decade. The prevalence of AF varies with age and sex. AF is present in 0.12%-0.16% of those younger than 49 years, in 3.7%-4.2% of those aged 60-70 years, and in 10%-17% of those aged 80 years or older. In addition, it occurs more frequently in males, with a male to female ratio of 1.2:1. The incidence of AF ranges between 0.21 and 0.41 per 1,000 person/years. Permanent AF occurs in approximately 50% of patients, and paroxysmal and persistent AF in 25% each. AF is frequently associated with cardiac disease and comorbidities. The most common concomitant diseases are coronary artery disease, valvular heart disease, and cardiomyopathy. The most common comorbidities are hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, renal failure, stroke, and cognitive disturbance. Paroxysmal AF occurs in younger patients and with a reduced burden of both cardiac disease and comorbidities. Generally, the history of AF is long, burdened by frequent recurrences, and associated with symptoms (in two thirds of patients). Patients with AF have a five-fold and two-fold higher risk of stroke and death, respectively. We estimate that the number of patients with AF in 2030 in Europe will be 14-17 million and the number of new cases of AF per year at 120,000-215,000. Given that AF is associated with significant morbidity and mortality, this increasing number of individuals with AF will have major public health implications.
Audience Academic
Author Zoni-Berisso, Massimo
Carazza, Tiziana
Lercari, Fabrizio
Domenicucci, Stefano
AuthorAffiliation Department of Cardiology, ASL 3, Padre A Micone Hospital, Genoa, Italy
AuthorAffiliation_xml – name: Department of Cardiology, ASL 3, Padre A Micone Hospital, Genoa, Italy
Author_xml – sequence: 1
  givenname: Massimo
  surname: Zoni-Berisso
  fullname: Zoni-Berisso, Massimo
– sequence: 2
  givenname: Fabrizio
  surname: Lercari
  fullname: Lercari, Fabrizio
– sequence: 3
  givenname: Tiziana
  surname: Carazza
  fullname: Carazza, Tiziana
– sequence: 4
  givenname: Stefano
  surname: Domenicucci
  fullname: Domenicucci, Stefano
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24966695$$D View this record in MEDLINE/PubMed
BookMark eNptkt9r2zAQx8XoWLuuT3sfhsEYlGT6aVt7GJSQboXABtuehSxLiYJieZJd6H-_c9OWpNR6sH363Peku-9bdNLFziL0nuA5Jbz6slgtf81_84rV4hU6I6SSM8K4PDn4PkUXOW8xPIyRqsJv0CnlsixLKc6QXPa-tTsfQ1zfFdEVekheh8L5JvkQ9OBj97VYjin2VndFb1PurRn8rX2HXjsdsr14eJ-jv9fLP4sfs9XP7zeLq9XMiFIOM0OxJhWWjPOKO-cIr7GGCK_hzJxa2eK2rNqqrpuaNpKWFhurMddUUqlbx87RzV63jXqr-uR3Ot2pqL26D8S0VjoN3gSrpCWucY5JDvfmJYOi8E-dsKLhtTGg9W2v1Y_NzrbGdkPS4Uj0eKfzG7WOt4rjkktBQeDzg0CK_0abB7Xz2VhoVGfjmBURULpmAgtAPz5Dt3FMHbRKUUo5h4kB-0StNVzAdy5CXTOJqiuOMRWslBM1f4GCNY3OgCOch_hRwqeDhI3VYdjkGMZpnPkY_HDYkadWPDoEALIHTIo5J-uU8cO9LeAIPiiC1WRENRlR7Y0IOZfPch5lX6L_A8jn2iw
CitedBy_id crossref_primary_10_35336_VA_2021_3_5_12
crossref_primary_10_1111_bcp_14221
crossref_primary_10_15407_internalmed2021_02_103
crossref_primary_10_1007_s10840_018_0370_y
crossref_primary_10_1093_eurheartj_ehw210
crossref_primary_10_1016_j_vph_2016_03_006
crossref_primary_10_1007_s12325_024_02895_w
crossref_primary_10_1016_j_ijcha_2019_100461
crossref_primary_10_3389_fmed_2019_00175
crossref_primary_10_1177_1708538119881077
crossref_primary_10_61189_061485jysfwu
crossref_primary_10_1093_ejcts_ezw313
crossref_primary_10_3389_fcvm_2021_689313
crossref_primary_10_1111_jce_15317
crossref_primary_10_1177_03331024241254517
crossref_primary_10_1186_s12916_022_02505_y
crossref_primary_10_1055_a_2337_4025
crossref_primary_10_1016_j_ejim_2024_03_014
crossref_primary_10_1016_j_ijcard_2018_11_127
crossref_primary_10_1016_j_cvdhj_2020_08_004
crossref_primary_10_1016_j_ijcard_2021_03_015
crossref_primary_10_1093_ageing_afab273
crossref_primary_10_1109_JBHI_2022_3199910
crossref_primary_10_1080_1354750X_2020_1814414
crossref_primary_10_1111_pace_13353
crossref_primary_10_1186_s12889_020_8275_y
crossref_primary_10_1002_joa3_13038
crossref_primary_10_2196_48748
crossref_primary_10_1016_j_ceh_2024_03_001
crossref_primary_10_21886_2712_8156_2023_4_4_41_50
crossref_primary_10_1111_eci_13385
crossref_primary_10_1007_s00424_017_2054_3
crossref_primary_10_1186_s12864_020_06944_w
crossref_primary_10_1016_j_medcli_2024_05_013
crossref_primary_10_1186_s12913_024_11100_1
crossref_primary_10_1016_j_ijcard_2021_11_008
crossref_primary_10_1155_2021_9996047
crossref_primary_10_1098_rsos_171214
crossref_primary_10_1111_echo_13899
crossref_primary_10_1136_bmj_n379
crossref_primary_10_1161_JAHA_124_036832
crossref_primary_10_1590_0004_282x20200105
crossref_primary_10_1016_j_ejphar_2017_03_039
crossref_primary_10_5551_jat_63574
crossref_primary_10_1161_CIRCEP_118_006242
crossref_primary_10_1002_mds_29596
crossref_primary_10_1186_s43044_022_00291_9
crossref_primary_10_1371_journal_pone_0226730
crossref_primary_10_1111_pace_14697
crossref_primary_10_1253_circrep_CR_20_0139
crossref_primary_10_17116_kardio202013061530
crossref_primary_10_1186_s12872_019_1105_4
crossref_primary_10_1016_j_dld_2021_11_011
crossref_primary_10_1111_ene_13538
crossref_primary_10_5301_GTND_2017_17030
crossref_primary_10_1001_jamanetworkopen_2021_40071
crossref_primary_10_1016_j_amjcard_2014_12_003
crossref_primary_10_1109_TMI_2019_2946345
crossref_primary_10_36660_abc_20201003
crossref_primary_10_1016_j_cmpb_2019_05_028
crossref_primary_10_1093_europace_euac144
crossref_primary_10_3109_15412555_2015_1043425
crossref_primary_10_35336_VA_1309
crossref_primary_10_1016_j_amjcard_2020_03_050
crossref_primary_10_1007_s10557_020_07103_9
crossref_primary_10_17925_EJAE_2018_4_2_56
crossref_primary_10_1002_clc_23452
crossref_primary_10_1016_j_artres_2018_05_004
crossref_primary_10_1097_FJC_0000000000000338
crossref_primary_10_1016_j_crvasa_2017_06_008
crossref_primary_10_1177_1074248419879089
crossref_primary_10_1016_j_sipas_2022_100153
crossref_primary_10_1093_ehjqcco_qcw031
crossref_primary_10_1111_jce_14598
crossref_primary_10_1016_j_recesp_2020_10_022
crossref_primary_10_1007_s11897_019_00430_5
crossref_primary_10_1093_ageing_afad216
crossref_primary_10_1093_icvts_ivy210
crossref_primary_10_1002_hon_2655
crossref_primary_10_1136_bmjopen_2019_033712
crossref_primary_10_1016_j_ahj_2019_04_015
crossref_primary_10_1093_ehjcvp_pvz016
crossref_primary_10_1016_j_blre_2019_03_005
crossref_primary_10_1016_j_breast_2019_05_017
crossref_primary_10_1016_j_clinsp_2022_100014
crossref_primary_10_1093_eurheartj_ehz834
crossref_primary_10_1038_s41569_020_00459_3
crossref_primary_10_3389_fcvm_2020_615927
crossref_primary_10_1113_EP086589
crossref_primary_10_1002_cre2_70041
crossref_primary_10_1007_s12350_023_03248_w
crossref_primary_10_2217_fca_15_31
crossref_primary_10_1177_2047487315624524
crossref_primary_10_1016_j_camwa_2017_05_012
crossref_primary_10_1186_s12875_017_0588_2
crossref_primary_10_1136_openhrt_2023_002563
crossref_primary_10_1002_clc_23329
crossref_primary_10_1097_MS9_0000000000001605
crossref_primary_10_3892_mmr_2017_6477
crossref_primary_10_1109_JIOT_2022_3188771
crossref_primary_10_1080_14017431_2018_1546892
crossref_primary_10_1136_heartjnl_2020_317612
crossref_primary_10_61186_hsm_3_4_348
crossref_primary_10_1177_0037549718782401
crossref_primary_10_1007_s11239_018_1634_1
crossref_primary_10_1186_s12913_019_4372_y
crossref_primary_10_1016_j_arr_2021_101527
crossref_primary_10_1016_j_ultrasmedbio_2018_02_004
crossref_primary_10_1186_s12889_022_12628_9
crossref_primary_10_2174_0929867326666191213095554
crossref_primary_10_1080_14779072_2018_1533118
crossref_primary_10_1016_j_cjca_2018_08_018
crossref_primary_10_1093_ehjqcco_qcad060
crossref_primary_10_1186_s13049_021_00866_6
crossref_primary_10_20996_1819_6446_2019_15_4_530_537
crossref_primary_10_3389_fphys_2020_00912
crossref_primary_10_1007_s10557_020_06971_5
crossref_primary_10_1177_1479164117735013
crossref_primary_10_1253_circrep_CR_23_0007
crossref_primary_10_1016_j_pec_2019_03_015
crossref_primary_10_1016_j_cmpb_2025_108606
crossref_primary_10_1186_s13561_022_00362_2
crossref_primary_10_1136_bmjopen_2016_013180
crossref_primary_10_1172_jci_insight_99941
crossref_primary_10_1136_bmjebm_2020_111634
crossref_primary_10_1007_s00391_022_02017_7
crossref_primary_10_1136_openhrt_2019_001165
crossref_primary_10_1080_14779072_2017_1355237
crossref_primary_10_1016_j_rxeng_2025_01_002
crossref_primary_10_1186_s13019_023_02189_2
crossref_primary_10_1007_s00380_022_02101_3
crossref_primary_10_1161_JAHA_119_013053
crossref_primary_10_1016_j_compbiomed_2019_103540
crossref_primary_10_1093_eurjcn_zvae164
crossref_primary_10_29045_14784726_2022_06_7_1_51
crossref_primary_10_1007_s12471_020_01528_5
crossref_primary_10_1093_ehjcvp_pvy026
crossref_primary_10_1161_CIRCRESAHA_119_315686
crossref_primary_10_1016_j_jcct_2018_06_005
crossref_primary_10_1007_s12928_024_00984_9
crossref_primary_10_1016_j_nrl_2021_06_004
crossref_primary_10_3389_fcvm_2021_720129
crossref_primary_10_1253_circj_CJ_19_0974
crossref_primary_10_1161_JAHA_117_006057
crossref_primary_10_1088_1361_6579_ab2cb8
crossref_primary_10_1136_jech_2019_212720
crossref_primary_10_1016_j_jtha_2024_07_011
crossref_primary_10_1136_openhrt_2023_002544
crossref_primary_10_1080_22423982_2024_2311965
crossref_primary_10_23736_S2724_5683_24_06464_0
crossref_primary_10_23950_1812_2892_JCMK_00542
crossref_primary_10_1016_j_hrthm_2020_09_017
crossref_primary_10_1016_j_ijcha_2020_100709
crossref_primary_10_1111_pace_14413
crossref_primary_10_31083_j_rcm2307242
crossref_primary_10_1016_j_ccep_2019_11_003
crossref_primary_10_1016_j_ijcard_2018_03_063
crossref_primary_10_1186_s13102_024_01000_6
crossref_primary_10_1016_j_hroo_2021_09_004
crossref_primary_10_1371_journal_pmed_1003197
crossref_primary_10_1007_s10554_021_02331_y
crossref_primary_10_1093_eurheartj_ehy778
crossref_primary_10_1016_j_jpsychores_2023_111542
crossref_primary_10_1097_XEB_0000000000000190
crossref_primary_10_20538_1682_0363_2019_4_209_221
crossref_primary_10_5507_bp_2018_083
crossref_primary_10_1136_openhrt_2019_001026
crossref_primary_10_1080_17425255_2017_1258054
crossref_primary_10_7759_cureus_16027
crossref_primary_10_1016_j_amjcard_2019_05_040
crossref_primary_10_3389_fcvm_2023_1207064
crossref_primary_10_1016_j_ajmo_2022_100026
crossref_primary_10_1186_s13049_017_0424_7
crossref_primary_10_1016_j_jtcvs_2019_10_186
crossref_primary_10_1016_j_bbrc_2019_03_074
crossref_primary_10_1016_j_diii_2021_05_010
crossref_primary_10_1016_j_medcle_2024_05_010
crossref_primary_10_1007_s12181_017_0206_5
crossref_primary_10_1016_j_thromres_2022_03_011
crossref_primary_10_1093_ehjqcco_qcy015
crossref_primary_10_1007_s10840_020_00709_x
crossref_primary_10_1007_s11239_020_02194_5
crossref_primary_10_1016_j_compbiomed_2019_103444
crossref_primary_10_15420_aer_2021_01
crossref_primary_10_1093_europace_euw211
crossref_primary_10_1155_2022_9295326
crossref_primary_10_1177_1076029620910808
crossref_primary_10_1016_j_ijcha_2022_101130
crossref_primary_10_5812_mca_141645
crossref_primary_10_3892_mmr_2018_9124
crossref_primary_10_1016_j_ijcard_2017_02_074
crossref_primary_10_1016_j_jmh_2025_100306
crossref_primary_10_1002_clc_24335
crossref_primary_10_1007_s00380_023_02278_1
crossref_primary_10_1016_j_vhri_2019_05_004
crossref_primary_10_1038_jhh_2017_23
crossref_primary_10_1371_journal_pone_0259652
crossref_primary_10_2196_24461
crossref_primary_10_1016_j_ijcard_2023_131595
crossref_primary_10_1182_bloodadvances_2017015461
crossref_primary_10_1080_14740338_2019_1676723
crossref_primary_10_1016_j_hrcr_2024_04_011
crossref_primary_10_1016_j_jstrokecerebrovasdis_2016_05_030
crossref_primary_10_1371_journal_pone_0269867
crossref_primary_10_1161_STROKEAHA_115_011476
crossref_primary_10_24835_1607_0763_2018_3_33_48
crossref_primary_10_7243_2053_7662_4_8
crossref_primary_10_33590_emjcardiol_10310415
crossref_primary_10_1016_j_ijcha_2022_100991
crossref_primary_10_1016_j_maturitas_2020_10_012
crossref_primary_10_1007_s00228_017_2296_1
crossref_primary_10_1093_europace_euaa261
crossref_primary_10_23736_S0026_4806_18_05824_X
crossref_primary_10_1097_MD_0000000000014549
crossref_primary_10_1093_ehjcvp_pvaa018
crossref_primary_10_1016_j_bbamcr_2022_119365
crossref_primary_10_1002_pdi_2155
crossref_primary_10_1016_j_ajem_2020_09_046
crossref_primary_10_1016_j_bspc_2019_101819
crossref_primary_10_3904_kjim_2015_224
crossref_primary_10_1002_clc_24240
crossref_primary_10_1016_j_medcli_2021_01_003
crossref_primary_10_1016_j_pjnns_2017_07_005
crossref_primary_10_1016_j_medcle_2021_01_010
crossref_primary_10_1111_jch_13931
crossref_primary_10_1186_s13020_023_00812_x
crossref_primary_10_1016_j_jaccao_2021_05_004
crossref_primary_10_1016_j_cmpb_2020_105753
crossref_primary_10_1016_j_amjcard_2015_04_013
crossref_primary_10_1016_j_ihj_2016_06_006
crossref_primary_10_1016_S1636_5410_19_42595_6
crossref_primary_10_1016_j_recesp_2017_01_027
crossref_primary_10_1093_ejendo_lvae117
crossref_primary_10_1016_j_socscimed_2024_116944
crossref_primary_10_1016_j_jjcc_2018_02_018
crossref_primary_10_1097_HJH_0000000000001731
crossref_primary_10_1016_j_poamed_2016_03_003
crossref_primary_10_7759_cureus_47278
crossref_primary_10_1097_MD_0000000000014544
crossref_primary_10_1038_s41598_024_60298_x
crossref_primary_10_1007_s10877_020_00458_2
crossref_primary_10_1016_j_mhp_2022_200245
crossref_primary_10_1016_j_jacl_2019_12_002
crossref_primary_10_1177_2333721419859687
crossref_primary_10_1007_s10840_023_01680_z
crossref_primary_10_1515_rrlm_2017_0041
crossref_primary_10_2147_IJGM_S366956
crossref_primary_10_1016_j_hjc_2020_11_007
crossref_primary_10_1016_j_ijcard_2023_04_007
crossref_primary_10_1016_j_ijcard_2023_131445
crossref_primary_10_1080_07853890_2022_2117407
crossref_primary_10_1007_s00392_019_01418_w
crossref_primary_10_2478_rjdnmd_2018_0019
crossref_primary_10_1055_s_0041_1726331
crossref_primary_10_3109_14017431_2015_1103892
crossref_primary_10_1016_j_isci_2024_109609
crossref_primary_10_36660_abc_20230680
crossref_primary_10_1016_j_ijcard_2020_08_097
crossref_primary_10_1080_13543784_2021_1897786
crossref_primary_10_1016_j_clnu_2020_06_003
crossref_primary_10_1016_j_hrthm_2018_08_012
crossref_primary_10_1016_j_ejmg_2022_104459
crossref_primary_10_1053_j_jvca_2021_02_050
crossref_primary_10_1177_2047487319861226
crossref_primary_10_1016_j_hrthm_2015_12_030
crossref_primary_10_3389_fcvm_2023_1060030
crossref_primary_10_1161_JAHA_119_014287
crossref_primary_10_3389_fphys_2023_1209458
crossref_primary_10_1253_circj_CJ_20_0883
crossref_primary_10_1093_eurheartj_ehaa612
crossref_primary_10_1177_1074248420930136
crossref_primary_10_1016_j_ypmed_2023_107584
crossref_primary_10_1111_jocn_14373
crossref_primary_10_1016_j_ejim_2016_04_007
crossref_primary_10_1093_europace_euv202
crossref_primary_10_1038_s41598_017_04604_w
crossref_primary_10_1253_circj_CJ_17_0519
crossref_primary_10_1016_j_acvd_2016_08_001
crossref_primary_10_1136_heartjnl_2018_313350
crossref_primary_10_1080_00365521_2017_1410568
crossref_primary_10_3389_fcvm_2022_847163
crossref_primary_10_1136_bmjopen_2015_010745
crossref_primary_10_1093_europace_euaa139
crossref_primary_10_1111_anec_13059
crossref_primary_10_1109_OJEMB_2024_3401105
crossref_primary_10_2196_21436
crossref_primary_10_1016_j_heliyon_2023_e12887
crossref_primary_10_33667_2078_5631_2019_4_35_410__5_8
crossref_primary_10_29169_1927_5951_2019_09_02_6
crossref_primary_10_1136_bmjopen_2020_040054
crossref_primary_10_1159_000507046
crossref_primary_10_26442_00403660_2022_09_201891
crossref_primary_10_1016_j_rx_2023_06_008
crossref_primary_10_3389_fphar_2021_638445
crossref_primary_10_1002_14651858_CD014819
crossref_primary_10_1016_j_xjse_2024_100006
crossref_primary_10_1186_s12872_022_02865_6
crossref_primary_10_1016_j_compbiomed_2023_106719
crossref_primary_10_1016_j_mad_2020_111326
crossref_primary_10_1007_s11096_020_01025_0
crossref_primary_10_1016_j_tcm_2022_04_002
crossref_primary_10_33678_cor_2019_023
crossref_primary_10_1016_j_crphys_2021_12_001
crossref_primary_10_1097_MD_0000000000037750
crossref_primary_10_1136_heartjnl_2021_319120
crossref_primary_10_1111_bcp_14938
crossref_primary_10_1007_s11265_020_01531_4
crossref_primary_10_2174_1389200219666181011160133
crossref_primary_10_1161_CIRCEP_120_009288
crossref_primary_10_1097_CRD_0000000000000479
crossref_primary_10_1371_journal_pone_0125161
crossref_primary_10_2459_JCM_0000000000000236
crossref_primary_10_7861_clinmedicine_16_3_272
crossref_primary_10_1007_s00101_017_0334_0
crossref_primary_10_1007_s12551_020_00735_z
crossref_primary_10_1111_jce_16399
crossref_primary_10_1016_j_acvd_2019_02_003
crossref_primary_10_1159_000539289
crossref_primary_10_34921_amj_2023_2_024
crossref_primary_10_2217_cer_2019_0125
crossref_primary_10_1093_inthealth_ihy075
crossref_primary_10_6000_1929_6029_2023_12_06
crossref_primary_10_1002_pds_4192
crossref_primary_10_11124_JBIES_20_00168
crossref_primary_10_1177_1753944715605011
crossref_primary_10_1016_j_atherosclerosis_2020_08_026
crossref_primary_10_3389_fsurg_2024_1404450
crossref_primary_10_1016_j_lanepe_2024_101134
crossref_primary_10_1007_s11548_018_1874_8
crossref_primary_10_1038_s41598_019_40445_5
crossref_primary_10_2174_1381612826666200407150307
crossref_primary_10_1016_j_repce_2016_12_020
crossref_primary_10_1080_15421406_2017_1360572
crossref_primary_10_1371_journal_pone_0259916
crossref_primary_10_1111_imj_16101
crossref_primary_10_1016_j_jchf_2019_03_005
crossref_primary_10_1016_j_arcmed_2019_05_007
crossref_primary_10_1097_CRD_0000000000000493
crossref_primary_10_1002_joa3_12608
crossref_primary_10_1177_23969873211008770
crossref_primary_10_1002_jcsm_13401
crossref_primary_10_7759_cureus_25252
crossref_primary_10_2196_23425
crossref_primary_10_1016_j_jval_2016_07_007
crossref_primary_10_1016_j_ahj_2016_05_014
crossref_primary_10_1093_icvts_ivx446
crossref_primary_10_1259_bjr_20211274
crossref_primary_10_1186_s10020_025_01162_0
crossref_primary_10_3389_fcell_2024_1298007
crossref_primary_10_1213_ANE_0000000000002070
crossref_primary_10_1536_ihj_20_238
crossref_primary_10_1007_s10654_017_0283_6
crossref_primary_10_1097_HCO_0000000000000245
crossref_primary_10_1007_s12325_020_01307_z
crossref_primary_10_1016_j_amjcard_2021_12_039
crossref_primary_10_1016_j_amjcard_2016_06_009
crossref_primary_10_1016_j_ahj_2020_02_016
crossref_primary_10_1038_s41371_019_0279_7
crossref_primary_10_1093_ehjqcco_qcac023
crossref_primary_10_1146_annurev_physiol_021317_121454
crossref_primary_10_1056_NEJMc1409495
crossref_primary_10_1007_s12551_017_0255_9
crossref_primary_10_1177_2048872618758931
crossref_primary_10_1007_s00740_018_0217_2
crossref_primary_10_1186_s12872_024_04215_0
crossref_primary_10_1007_s40520_019_01152_3
crossref_primary_10_1111_jocs_15844
crossref_primary_10_1016_j_amjmed_2020_08_026
crossref_primary_10_1016_j_hroo_2024_12_006
crossref_primary_10_1097_MD_0000000000028797
crossref_primary_10_1007_s00134_019_05633_x
crossref_primary_10_1111_jce_13936
crossref_primary_10_1586_14779072_2015_1026259
crossref_primary_10_1097_MJT_0000000000000590
crossref_primary_10_1111_eci_13952
crossref_primary_10_1111_imj_13777
crossref_primary_10_1097_01_JAA_0000944600_04370_48
crossref_primary_10_1016_j_hlc_2019_05_185
crossref_primary_10_1093_europace_euaa421
crossref_primary_10_23736_S2724_5683_22_05841_0
crossref_primary_10_1007_s10840_019_00603_1
crossref_primary_10_1093_eurheartj_suaa176
crossref_primary_10_1016_j_ajem_2023_05_041
crossref_primary_10_1093_eurheartj_suaa179
crossref_primary_10_54359_ps_v14i76_137
crossref_primary_10_1016_j_cellsig_2022_110475
crossref_primary_10_35366_94772
crossref_primary_10_1016_j_ijcard_2015_11_084
crossref_primary_10_1016_j_jelectrocard_2019_12_009
crossref_primary_10_22141_2224_0586_17_4_2021_237735
crossref_primary_10_3389_fneur_2023_1269651
crossref_primary_10_1016_j_ccep_2020_10_002
crossref_primary_10_1177_23247096211010048
crossref_primary_10_1111_jch_14848
crossref_primary_10_1109_TSP_2020_3006766
crossref_primary_10_1016_j_cardfail_2024_05_017
crossref_primary_10_1080_17434440_2022_2141112
crossref_primary_10_1093_eurheartj_suv037
crossref_primary_10_1097_MJT_0000000000000344
crossref_primary_10_1128_mSphere_00071_20
crossref_primary_10_1161_JAHA_118_009024
crossref_primary_10_1016_j_jaccas_2020_02_027
crossref_primary_10_1080_14737167_2021_1979961
crossref_primary_10_1080_13696998_2020_1752220
crossref_primary_10_1253_circj_CJ_21_0180
crossref_primary_10_1016_j_jacc_2016_06_062
crossref_primary_10_1016_j_yjmcc_2014_12_005
crossref_primary_10_1016_j_fitote_2019_104272
crossref_primary_10_3389_fphys_2019_01138
crossref_primary_10_1016_j_cpcardiol_2023_102024
crossref_primary_10_1007_s40266_020_00771_0
crossref_primary_10_1016_j_thromres_2016_04_022
crossref_primary_10_3389_fgene_2022_1003366
crossref_primary_10_1016_j_cmpb_2019_105219
crossref_primary_10_1016_j_ienj_2017_03_006
crossref_primary_10_1016_j_bspc_2020_102194
crossref_primary_10_1093_icvts_ivab322
crossref_primary_10_1002_vrc2_1031
crossref_primary_10_1136_ebnurs_2019_103151
crossref_primary_10_1111_ijcp_14042
crossref_primary_10_56294_hl2023202
crossref_primary_10_1016_j_rec_2018_06_027
crossref_primary_10_1093_fampra_cmab057
crossref_primary_10_1111_jch_13755
crossref_primary_10_1007_s12410_019_9520_6
crossref_primary_10_3389_fphar_2018_01005
crossref_primary_10_1080_07853890_2024_2423789
crossref_primary_10_1093_rheumatology_kead336
crossref_primary_10_1016_j_jacasi_2021_10_009
crossref_primary_10_17116_terarkh2017899120_127
crossref_primary_10_1016_j_amjcard_2023_11_009
crossref_primary_10_1016_j_gene_2015_08_062
crossref_primary_10_1111_1753_0407_13432
crossref_primary_10_1016_j_nrleng_2021_06_005
crossref_primary_10_17802_2306_1278_2018_7_3_12_23
crossref_primary_10_1002_ehf2_14607
crossref_primary_10_1016_j_hrthm_2024_04_012
crossref_primary_10_1177_03000605211057822
crossref_primary_10_1177_2047487318777387
crossref_primary_10_1016_j_mad_2017_09_002
crossref_primary_10_22328_2413_5747_2019_5_3_7_16
crossref_primary_10_1038_s41684_023_01141_0
crossref_primary_10_1016_j_jelectrocard_2019_04_010
crossref_primary_10_15829_1560_4071_2018_11_96_99
crossref_primary_10_1016_j_heliyon_2024_e25295
crossref_primary_10_1088_1361_6579_aae304
crossref_primary_10_1186_s40248_015_0023_2
crossref_primary_10_1016_j_mehy_2014_11_012
crossref_primary_10_1016_j_med_2017_07_010
crossref_primary_10_1136_eb_2017_102741
crossref_primary_10_2217_cer_2019_0070
crossref_primary_10_1016_j_cjco_2021_09_006
crossref_primary_10_1093_europace_euy160
crossref_primary_10_2459_JCM_0000000000000986
crossref_primary_10_1016_j_amjcard_2019_11_021
crossref_primary_10_1177_1753944719891688
crossref_primary_10_1080_17434440_2022_2096437
crossref_primary_10_1002_jppr_1715
crossref_primary_10_1016_j_ijcard_2018_07_066
crossref_primary_10_1111_joim_13393
crossref_primary_10_1093_cvr_cvac016
crossref_primary_10_7326_M21_3498
crossref_primary_10_15406_ppij_2019_07_00235
crossref_primary_10_1016_j_ahj_2016_03_001
crossref_primary_10_3389_fcvm_2023_1067964
crossref_primary_10_1097_MD_0000000000003102
crossref_primary_10_32415_jscientia_2019_07_02
crossref_primary_10_1088_1361_6579_aad9f0
crossref_primary_10_1177_1049732320951772
crossref_primary_10_1161_STROKEAHA_115_009487
crossref_primary_10_54359_ps_v13i74_161
crossref_primary_10_1186_s12933_021_01318_2
crossref_primary_10_1016_j_knosys_2020_106589
crossref_primary_10_2217_cer_2019_0089
crossref_primary_10_1080_14779072_2020_1734452
crossref_primary_10_1111_jce_14930
crossref_primary_10_1186_s13195_019_0496_x
crossref_primary_10_1007_s12603_020_1507_0
crossref_primary_10_1016_j_hroo_2022_07_008
crossref_primary_10_15212_CVIA_2016_0060
crossref_primary_10_1016_j_ijmedinf_2022_104790
crossref_primary_10_1016_j_ijrobp_2020_10_036
crossref_primary_10_1016_j_repce_2014_08_006
crossref_primary_10_1111_dom_14243
crossref_primary_10_36660_abc_20230680i
crossref_primary_10_1177_1076029615619485
crossref_primary_10_1016_j_ijcard_2018_07_051
crossref_primary_10_1124_jpet_116_234591
crossref_primary_10_1016_j_mayocp_2021_12_018
crossref_primary_10_1186_s12933_019_0983_1
crossref_primary_10_1186_s12872_024_04086_5
crossref_primary_10_1080_03007995_2022_2061705
crossref_primary_10_1016_j_tet_2022_132874
crossref_primary_10_1161_STROKEAHA_115_009371
crossref_primary_10_1016_j_eswa_2018_08_011
crossref_primary_10_1016_j_bspc_2019_101563
crossref_primary_10_2478_prolas_2020_0001
crossref_primary_10_1016_j_hrthm_2024_04_064
crossref_primary_10_1016_j_emc_2020_12_001
crossref_primary_10_1016_j_jval_2017_06_005
crossref_primary_10_1111_bph_14043
crossref_primary_10_1371_journal_pone_0195175
crossref_primary_10_1016_j_ancard_2018_09_013
crossref_primary_10_1161_JAHA_123_033840
crossref_primary_10_1007_s11739_019_02151_y
crossref_primary_10_1186_s40359_023_01457_z
crossref_primary_10_3389_fneur_2021_721337
crossref_primary_10_1016_j_amjmed_2021_10_021
crossref_primary_10_1080_21691401_2019_1637885
crossref_primary_10_1038_s41598_024_67100_y
crossref_primary_10_12968_hmed_2019_80_6_C82
crossref_primary_10_1038_s41598_021_02179_1
crossref_primary_10_1186_s12872_022_02737_z
crossref_primary_10_33590_emjcardiol_10312782
crossref_primary_10_1111_jocn_14852
crossref_primary_10_1161_JAHA_118_011112
crossref_primary_10_1016_j_jacep_2024_12_007
crossref_primary_10_1016_j_jstrokecerebrovasdis_2017_01_022
crossref_primary_10_1038_s41572_022_00347_9
crossref_primary_10_7759_cureus_53093
crossref_primary_10_1007_s11606_019_05073_9
crossref_primary_10_2217_cer_15_44
crossref_primary_10_3389_fmed_2020_00414
crossref_primary_10_1080_17843286_2021_1913547
crossref_primary_10_1111_pace_15090
crossref_primary_10_1124_pr_117_014183
crossref_primary_10_15829_1560_4071_2018_12_119_124
crossref_primary_10_1016_j_rccl_2022_06_005
crossref_primary_10_1093_eurheartj_suab153
crossref_primary_10_1136_jmedgenet_2019_106676
crossref_primary_10_1098_rstb_2022_0174
crossref_primary_10_1016_j_ahj_2023_11_015
crossref_primary_10_1080_01616412_2020_1738648
crossref_primary_10_1038_s41569_019_0179_0
crossref_primary_10_1080_08820139_2021_1884091
crossref_primary_10_20514_2226_6704_2025_15_1_17_23
crossref_primary_10_1007_s10439_017_1832_6
crossref_primary_10_1093_europace_eux031
crossref_primary_10_1007_s00059_016_4423_7
crossref_primary_10_1186_s13063_021_05497_x
crossref_primary_10_1016_j_jaccas_2022_101702
crossref_primary_10_1007_s41870_023_01241_7
crossref_primary_10_1007_s00392_022_02117_9
crossref_primary_10_1177_1474515118804353
crossref_primary_10_1093_europace_euae183
crossref_primary_10_1098_rsos_221620
crossref_primary_10_1016_j_eswa_2022_118540
crossref_primary_10_1016_j_repc_2016_12_011
crossref_primary_10_1080_03007995_2017_1347090
crossref_primary_10_1111_1440_1681_12863
crossref_primary_10_1093_eurheartj_ehv513
crossref_primary_10_1088_1361_6579_aac552
crossref_primary_10_1111_pace_14282
crossref_primary_10_1016_j_bbe_2015_10_004
crossref_primary_10_1093_ehjci_jeac080
crossref_primary_10_1111_liv_12928
crossref_primary_10_21518_2079_701X_2019_21_58_64
crossref_primary_10_3389_fphar_2025_1362060
crossref_primary_10_1007_s11739_023_03375_9
crossref_primary_10_1016_j_amjcard_2016_09_002
crossref_primary_10_1016_j_hjc_2017_11_017
crossref_primary_10_1016_j_jjcc_2017_07_008
crossref_primary_10_2478_jim_2020_0012
crossref_primary_10_1177_2047487317740644
crossref_primary_10_1016_j_hrthm_2019_07_026
crossref_primary_10_24884_2072_6716_2021_22_2_32_37
crossref_primary_10_1111_bcp_14171
crossref_primary_10_35336_VA_2020_1_63_69
crossref_primary_10_1007_s00399_019_0633_z
crossref_primary_10_1111_jcmm_18582
crossref_primary_10_1007_s40292_019_00334_4
crossref_primary_10_1016_j_ahj_2021_08_020
crossref_primary_10_1016_j_ijcha_2022_101153
crossref_primary_10_1253_circj_CJ_19_0898
crossref_primary_10_1080_0886022X_2021_2019588
crossref_primary_10_1016_j_slast_2024_100186
crossref_primary_10_1016_j_jacep_2017_06_020
crossref_primary_10_1016_j_jstrokecerebrovasdis_2018_05_044
crossref_primary_10_1016_j_ahj_2022_09_002
crossref_primary_10_1007_s12325_021_01724_8
crossref_primary_10_1016_j_rec_2017_02_019
crossref_primary_10_1007_s10741_019_09837_7
crossref_primary_10_1007_s12603_020_1418_0
crossref_primary_10_1007_s12325_023_02544_8
crossref_primary_10_1136_bmjopen_2018_021704
crossref_primary_10_4103_heartviews_heartviews_80_22
crossref_primary_10_1016_j_comcom_2021_08_002
crossref_primary_10_1177_1474515117720326
crossref_primary_10_1016_j_jjcc_2017_12_010
crossref_primary_10_1093_europace_eux293
crossref_primary_10_2459_JCM_0000000000000962
crossref_primary_10_1016_j_repc_2014_08_005
crossref_primary_10_3389_fphys_2021_749635
crossref_primary_10_1177_0003319717722283
crossref_primary_10_1186_s12944_023_01990_1
crossref_primary_10_1097_MEJ_0000000000000402
crossref_primary_10_1080_14779072_2017_1340156
crossref_primary_10_1093_europace_euz119
crossref_primary_10_17116_kardio202114051400
crossref_primary_10_1093_europace_eux177
crossref_primary_10_3389_fphys_2018_01206
crossref_primary_10_5507_bp_2024_037
crossref_primary_10_2478_abm_2022_0016
crossref_primary_10_1016_j_ijcard_2018_02_066
crossref_primary_10_1016_j_jacbts_2019_05_005
crossref_primary_10_1016_j_cpcardiol_2024_102381
crossref_primary_10_1177_10760296211049786
crossref_primary_10_1042_CS20150586
crossref_primary_10_1161_JAHA_121_021224
crossref_primary_10_3389_fphys_2022_1030307
crossref_primary_10_1016_j_ancard_2024_101803
crossref_primary_10_24125_sanamed_v15i2_417
crossref_primary_10_3389_fcvm_2020_00067
crossref_primary_10_1007_s00059_024_05275_w
crossref_primary_10_1161_CIRCEP_118_007030
crossref_primary_10_1016_j_hrthm_2021_01_018
crossref_primary_10_1111_jce_14638
crossref_primary_10_1111_nyas_14332
crossref_primary_10_3892_ijmm_2019_4063
crossref_primary_10_4254_wjh_v10_i10_761
crossref_primary_10_4103_IJCA_IJCA_61_19
crossref_primary_10_1007_s40675_018_0130_7
crossref_primary_10_1016_j_recesp_2018_05_001
crossref_primary_10_1111_jce_14878
crossref_primary_10_1016_j_ijcard_2019_04_061
crossref_primary_10_15420_ecr_2018_32_2
crossref_primary_10_1111_joic_12531
crossref_primary_10_1177_0268355521994997
crossref_primary_10_1093_cvr_cvab017
crossref_primary_10_1007_s40620_020_00720_5
crossref_primary_10_1016_S1474_4422_17_30016_9
crossref_primary_10_3389_fcvm_2024_1303540
crossref_primary_10_1177_1474515117733731
crossref_primary_10_1007_s11886_018_1033_4
crossref_primary_10_1111_jocs_16248
crossref_primary_10_1111_jce_13454
crossref_primary_10_3389_fphys_2018_01221
crossref_primary_10_1016_j_echo_2021_01_004
crossref_primary_10_1016_j_irbm_2022_04_008
crossref_primary_10_1017_cjn_2022_25
crossref_primary_10_1007_s00059_019_4828_1
crossref_primary_10_7759_cureus_45958
crossref_primary_10_1007_s00399_017_0484_4
crossref_primary_10_1016_j_hroo_2024_07_016
crossref_primary_10_1016_j_ultrasmedbio_2017_06_019
crossref_primary_10_1016_j_nmd_2021_01_002
crossref_primary_10_18087_cardio_2019_10_n612
crossref_primary_10_1016_j_ijcha_2024_101372
crossref_primary_10_3238_arztebl_m2021_0150
crossref_primary_10_1016_j_ijcrp_2024_200249
crossref_primary_10_1111_pace_13272
crossref_primary_10_1111_anec_12951
crossref_primary_10_1080_07853890_2021_1875499
crossref_primary_10_1093_ageing_afw104
crossref_primary_10_1016_j_numecd_2018_02_008
crossref_primary_10_1111_joim_12902
crossref_primary_10_1155_2017_2163610
crossref_primary_10_1016_j_compbiomed_2019_103386
crossref_primary_10_1111_jce_14775
crossref_primary_10_3389_fphys_2018_01211
crossref_primary_10_1016_j_cmpb_2016_04_009
crossref_primary_10_3389_fcvm_2020_00003
crossref_primary_10_3389_fcvm_2021_730453
crossref_primary_10_1093_europace_euad185
crossref_primary_10_3389_fphar_2024_1435545
crossref_primary_10_1093_europace_eux127
crossref_primary_10_35440_hutfd_1127431
crossref_primary_10_1063_1_4999611
crossref_primary_10_1016_j_jjcc_2018_06_005
crossref_primary_10_1080_13696998_2024_2399438
crossref_primary_10_1016_j_ijcha_2019_100423
crossref_primary_10_17343_sdutfd_1206357
crossref_primary_10_1136_bmjopen_2017_020282
crossref_primary_10_1136_bmjopen_2017_021121
crossref_primary_10_1093_eurheartj_ehaa1084
crossref_primary_10_1097_01_JAA_0000769672_18363_3f
crossref_primary_10_1080_23808993_2020_1735935
crossref_primary_10_33590_emjcardiol_10310292
crossref_primary_10_1002_clc_22895
crossref_primary_10_1080_14737167_2024_2377663
crossref_primary_10_1186_s42444_022_00064_0
crossref_primary_10_7717_peerj_3537
crossref_primary_10_1016_j_ijcard_2018_02_075
crossref_primary_10_3389_fcvm_2020_00132
crossref_primary_10_1016_j_jcin_2019_08_054
crossref_primary_10_1080_00015385_2020_1799573
crossref_primary_10_1111_echo_15572
crossref_primary_10_1007_s00392_021_01959_z
crossref_primary_10_1159_000536585
crossref_primary_10_1177_1747493019897870
crossref_primary_10_1007_s00394_019_01952_3
crossref_primary_10_3389_fneur_2023_1123518
crossref_primary_10_1093_cvr_cvaa258
crossref_primary_10_1111_ijcp_13434
crossref_primary_10_2196_29408
crossref_primary_10_1080_00365521_2023_2239973
crossref_primary_10_1016_j_bspc_2021_102500
crossref_primary_10_4244_EIJ_D_24_00100
crossref_primary_10_1038_s41598_020_77562_5
crossref_primary_10_3389_fcvm_2022_879984
crossref_primary_10_2139_ssrn_4097521
crossref_primary_10_4103_ATMR_ATMR_209_24
crossref_primary_10_1007_s12350_018_01480_3
crossref_primary_10_1016_j_jamda_2018_04_017
crossref_primary_10_1136_heartjnl_2024_323950
crossref_primary_10_1038_s41397_017_0007_z
crossref_primary_10_1093_europace_euw295
crossref_primary_10_12968_bjca_2017_12_6_265
crossref_primary_10_1038_s41746_019_0207_9
crossref_primary_10_1093_eurpub_cky075
crossref_primary_10_1017_S1463423619000355
crossref_primary_10_1016_j_ejim_2019_04_024
crossref_primary_10_1080_14656566_2020_1789099
crossref_primary_10_1111_jce_15768
crossref_primary_10_1016_j_amjcard_2018_05_015
crossref_primary_10_1097_FJC_0000000000000703
crossref_primary_10_1088_2057_1976_ab1104
crossref_primary_10_1055_s_0041_1735809
crossref_primary_10_31083_j_rcm2308272
crossref_primary_10_1002_ccd_29791
crossref_primary_10_1186_s43044_025_00605_7
crossref_primary_10_1371_journal_pone_0170974
crossref_primary_10_1080_07853890_2023_2193426
crossref_primary_10_1016_j_ultrasmedbio_2016_11_017
crossref_primary_10_1016_j_arr_2020_101092
crossref_primary_10_1556_2066_2021_00048
crossref_primary_10_1002_clc_22677
crossref_primary_10_1007_s40520_022_02107_x
ContentType Journal Article
Copyright COPYRIGHT 2014 Dove Medical Press Limited
2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2014 Zoni-Berisso et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014
Copyright_xml – notice: COPYRIGHT 2014 Dove Medical Press Limited
– notice: 2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2014 Zoni-Berisso et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014
DBID AAYXX
CITATION
NPM
3V.
7XB
8C1
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.2147/CLEP.S47385
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
Public Health Database
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Public Health
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
ProQuest One Academic UKI Edition
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database





MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1179-1349
EndPage 220
ExternalDocumentID oai_doaj_org_article_9e1fbff394134463934fbf2f5e5b48cc
PMC4064952
A400253691
24966695
10_2147_CLEP_S47385
Genre Journal Article
Review
GeographicLocations Italy
United States--US
Europe
Iceland
Germany
GeographicLocations_xml – name: Italy
– name: Iceland
– name: Germany
– name: United States--US
– name: Europe
GroupedDBID ---
0YH
29B
2WC
53G
5VS
8C1
8G5
AAYXX
ABUWG
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
C1A
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
M2O
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RIG
RPM
TDBHL
TR2
UKHRP
VDV
NPM
PMFND
3V.
7XB
8FK
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c569t-c20a170934474fff1480aa174873842e9d0d67d788b82b926e0cea04a2929adf3
IEDL.DBID M48
ISSN 1179-1349
IngestDate Wed Aug 27 01:24:28 EDT 2025
Thu Aug 21 18:10:27 EDT 2025
Thu Jul 10 18:55:23 EDT 2025
Fri Jul 25 06:03:55 EDT 2025
Tue Jun 17 21:40:51 EDT 2025
Tue Jun 10 20:27:28 EDT 2025
Thu May 22 21:18:48 EDT 2025
Thu Apr 03 07:04:40 EDT 2025
Tue Jul 01 02:28:38 EDT 2025
Thu Apr 24 23:03:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue default
Keywords mortality
epidemiology
atrial fibrillation
risk factors
stroke
Language English
License http://creativecommons.org/licenses/by-nc/3.0
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c569t-c20a170934474fff1480aa174873842e9d0d67d788b82b926e0cea04a2929adf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/2224438541?pq-origsite=%requestingapplication%
PMID 24966695
PQID 2224438541
PQPubID 3933188
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_9e1fbff394134463934fbf2f5e5b48cc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4064952
proquest_miscellaneous_1541383505
proquest_journals_2224438541
gale_infotracmisc_A400253691
gale_infotracacademiconefile_A400253691
gale_healthsolutions_A400253691
pubmed_primary_24966695
crossref_citationtrail_10_2147_CLEP_S47385
crossref_primary_10_2147_CLEP_S47385
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
– name: Macclesfield
PublicationTitle Clinical epidemiology
PublicationTitleAlternate Clin Epidemiol
PublicationYear 2014
Publisher Dove Medical Press Limited
Taylor & Francis Ltd
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Taylor & Francis Ltd
– name: Dove Medical Press
References 16204266 - Eur Heart J. 2005 Nov;26(22):2422-34
11343485 - JAMA. 2001 May 9;285(18):2370-5
12771006 - Circulation. 2003 Jun 17;107(23):2920-5
15864238 - Am Heart J. 2005 Mar;149(3):489-96
21551478 - Europace. 2011 Aug;13(8):1110-7
23321349 - Eur Heart J. 2013 Apr;34(14):1061-7
23220354 - Europace. 2013 Apr;15(4):486-93
19153087 - Europace. 2009 Apr;11(4):423-34
17277353 - Heart. 2007 May;93(5):606-12
22795403 - Int J Cardiol. 2013 Sep 10;167(6):2682-7
22235070 - Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93
16253649 - Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):79-87
15119503 - Ital Heart J. 2004 Mar;5(3):205-13
23266657 - JAMA Intern Med. 2013 Jan 28;173(2):159-60
22514252 - Circulation. 2012 May 15;125(19):2298-307
24345399 - Circulation. 2014 Feb 25;129(8):837-47
24360776 - Am J Cardiol. 2014 Feb 15;113(4):655-61
16987906 - Europace. 2006 Sep;8(9):651-745
21920917 - Circ Heart Fail. 2011 Nov;4(6):740-6
9040682 - Stroke. 1997 Feb;28(2):316-21
19176537 - Eur Heart J. 2010 Apr;31(8):967-75
1866765 - Stroke. 1991 Aug;22(8):983-8
21610240 - JAMA. 2011 May 25;305(20):2080-7
23273528 - Am J Cardiol. 2013 Mar 1;111(5):705-11
17548732 - Circulation. 2007 Jun 19;115(24):3050-6
20170808 - J Am Coll Cardiol. 2010 Feb 23;55(8):725-31
22949543 - Circulation. 2012 Sep 4;126(10):e143-6
7062992 - N Engl J Med. 1982 Apr 29;306(17):1018-22
23478104 - Am J Emerg Med. 2013 May;31(5):792-7
22361078 - Circ Heart Fail. 2012 Mar 1;5(2):191-201
24119623 - J Stroke Cerebrovasc Dis. 2014 Feb;23 (2):e73-83
22787011 - Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9
17336723 - J Am Coll Cardiol. 2007 Mar 6;49(9):986-92
24774588 - Rev Esp Cardiol (Engl Ed). 2014 Apr;67(4):259-69
23900699 - Eur Heart J. 2013 Sep;34(35):2746-51
16818816 - Circulation. 2006 Jul 11;114(2):119-25
23879838 - J Intern Med. 2013 Nov;274(5):461-8
15851136 - Heart Rhythm. 2004 Jul;1(2 Suppl):B31-4, discussion B34-5
24236932 - Pacing Clin Electrophysiol. 2014 Mar;37(3):345-55
18397874 - Eur Heart J. 2008 May;29(9):1181-9
23393083 - Heart. 2013 Aug;99(16):1166-72
17673732 - BMJ. 2007 Aug 25;335(7616):383
19433768 - Circulation. 2009 May 12;119(18):2516-25
21533828 - Clin Res Cardiol. 2011 Oct;100(10):897-905
22884698 - Int J Cardiol. 2013 Sep 10;167(6):2895-903
10368121 - Circulation. 1999 Jun 15;99(23):3028-35
References_xml – reference: 11343485 - JAMA. 2001 May 9;285(18):2370-5
– reference: 24345399 - Circulation. 2014 Feb 25;129(8):837-47
– reference: 23900699 - Eur Heart J. 2013 Sep;34(35):2746-51
– reference: 23478104 - Am J Emerg Med. 2013 May;31(5):792-7
– reference: 19153087 - Europace. 2009 Apr;11(4):423-34
– reference: 15851136 - Heart Rhythm. 2004 Jul;1(2 Suppl):B31-4, discussion B34-5
– reference: 21610240 - JAMA. 2011 May 25;305(20):2080-7
– reference: 22514252 - Circulation. 2012 May 15;125(19):2298-307
– reference: 16818816 - Circulation. 2006 Jul 11;114(2):119-25
– reference: 16204266 - Eur Heart J. 2005 Nov;26(22):2422-34
– reference: 23220354 - Europace. 2013 Apr;15(4):486-93
– reference: 17277353 - Heart. 2007 May;93(5):606-12
– reference: 16987906 - Europace. 2006 Sep;8(9):651-745
– reference: 24774588 - Rev Esp Cardiol (Engl Ed). 2014 Apr;67(4):259-69
– reference: 12771006 - Circulation. 2003 Jun 17;107(23):2920-5
– reference: 23321349 - Eur Heart J. 2013 Apr;34(14):1061-7
– reference: 22884698 - Int J Cardiol. 2013 Sep 10;167(6):2895-903
– reference: 15864238 - Am Heart J. 2005 Mar;149(3):489-96
– reference: 24360776 - Am J Cardiol. 2014 Feb 15;113(4):655-61
– reference: 20170808 - J Am Coll Cardiol. 2010 Feb 23;55(8):725-31
– reference: 23273528 - Am J Cardiol. 2013 Mar 1;111(5):705-11
– reference: 22235070 - Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93
– reference: 24119623 - J Stroke Cerebrovasc Dis. 2014 Feb;23 (2):e73-83
– reference: 15119503 - Ital Heart J. 2004 Mar;5(3):205-13
– reference: 24236932 - Pacing Clin Electrophysiol. 2014 Mar;37(3):345-55
– reference: 23393083 - Heart. 2013 Aug;99(16):1166-72
– reference: 1866765 - Stroke. 1991 Aug;22(8):983-8
– reference: 17336723 - J Am Coll Cardiol. 2007 Mar 6;49(9):986-92
– reference: 19433768 - Circulation. 2009 May 12;119(18):2516-25
– reference: 9040682 - Stroke. 1997 Feb;28(2):316-21
– reference: 18397874 - Eur Heart J. 2008 May;29(9):1181-9
– reference: 16253649 - Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):79-87
– reference: 23879838 - J Intern Med. 2013 Nov;274(5):461-8
– reference: 22361078 - Circ Heart Fail. 2012 Mar 1;5(2):191-201
– reference: 10368121 - Circulation. 1999 Jun 15;99(23):3028-35
– reference: 21920917 - Circ Heart Fail. 2011 Nov;4(6):740-6
– reference: 19176537 - Eur Heart J. 2010 Apr;31(8):967-75
– reference: 22795403 - Int J Cardiol. 2013 Sep 10;167(6):2682-7
– reference: 21533828 - Clin Res Cardiol. 2011 Oct;100(10):897-905
– reference: 7062992 - N Engl J Med. 1982 Apr 29;306(17):1018-22
– reference: 17673732 - BMJ. 2007 Aug 25;335(7616):383
– reference: 23266657 - JAMA Intern Med. 2013 Jan 28;173(2):159-60
– reference: 17548732 - Circulation. 2007 Jun 19;115(24):3050-6
– reference: 22949543 - Circulation. 2012 Sep 4;126(10):e143-6
– reference: 21551478 - Europace. 2011 Aug;13(8):1110-7
– reference: 22787011 - Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9
SSID ssj0000331770
Score 2.5536616
SecondaryResourceType review_article
Snippet In the last 20 years, atrial fibrillation (AF) has become one of the most important public health problems and a significant cause of increasing health care...
Massimo Zoni-Berisso, Fabrizio Lercari, Tiziana Carazza, Stefano DomenicucciDepartment of Cardiology, ASL 3, Padre A Micone Hospital, Genoa, ItalyAbstract: In...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 213
SubjectTerms Acute coronary syndromes
Anticoagulants
Atrial fibrillation
Cardiac arrhythmia
Clinical medicine
Comorbidity
Complications and side effects
Epidemiology
Health care policy
Heart failure
Males
Mortality
Older people
Population
Public health
Review
Risk factors
Stroke
Studies
Trends
Womens health
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS8MwEA_ikyDit_OzgiAI1bbJ0sa3KRsiIoIKvoUkTVAY3XDzwf_eu6SrKwq--LjebTS3u-R-4e53hJyw3CIPmAGQY4qYCa1jZUoalzy3Qlma56Ha4p7fPLPbl-7L3KgvrAkL9MDBcBfCpk47RwXstgBdqKAMPmeua7uaFcbg7gtn3hyY8nswhXPRT4pDyrMYOfhCcx6O5bmA3x2fTxgSubSOI8_a_3Nvnjuc2oWTcyfRYJWs1Clk1AuvvkYWbLVOlsP9WxTaijaI6H-Pfv2MRi5Sfj5H5LDEfxgK4C6j2V18NP7uudwkz4P-0_VNXI9JiE2Xi2lsskSleSKQu4855wDgJAqeABShBcusKBOwfAlYVxeZFhm3ibEqYSqD1EiVjm6RxWpU2R0SlYlTlHNdckOZgeh0hbKYAyrFs1TzDjmbWUuamkMcR1kMJWAJNK28vus_yEdv2g45aZTHgTrjd7UrNHujgnzX_gF4gay9QP7lBR1yhH-aDM2jTdTKHsOkjnKRdsip18C4hVc2qm4_gIUjA1ZLc7-lCfFm2uKZY8g63icSsizGYDEMxMeNGL-JNWyVHX1MJCSrKYWEN4Elbwc_ahYNIBhwpABJ3vKwllXakurt1bOBQ0YGIDfb_Q8z7pElSAhZuGLaJ4vT9w97AEnXVB_6-PoC3iAnxw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS90wFA9OXwZjbLqP-tmBMBh0pk2aNnsRlSsiQ8RN8C0kabINpL3zXh_87z2nye21bPjY5BSak5yc8zs9H4Ts88phHTALIMfWGZfGZNo2LGtE5aR2rKpCtMWFOLvm5zflTXS4zWJY5eJO7C_qprPoIz8APcY5q0ueH07_Ztg1Cv-uxhYaL8gaXME1gK-148nF5dXgZaEM9GNFQ2IetuQ5OPk-ufz6g2MRl5Eq6iv2_3svP1FM46DJJ1ro9A15Hc3H9Cjs91uy4tp18ir43tKQUrRB5GTZ9vUh7Xyq-94cqcfw_tsQ_PYtXfjh0-ky3_IduT6d_Dw5y2KLhMyWQs4zW1CdV1Ri3T7uvQdwQzWMAAxhNS-cbChwvQGca-rCyEI4ap2mXBdgFunGs_dkte1a95GkDfWaCWEaYRm3IJm-1g7tP61FkRuRkC8Lbikb64djG4tbBTgCWauQtSqwNiH7A_E0lM34P9kxsn0gwVrX_UB390tF0VHS5d54zyToWwCvDBYLz4UvXWl4bW1C9nDTVEgcHSRWHXE06JiQeUI-9xQos_DJVsfUA1g4Vr8aUW6PKEHW7Hh6cTBUlPWZWp7MhHwapvFNjF9rXXc_U2Co5gyMXQpL_hDO0bBoAMCAISXMVKMTNuLKeKb987uvBA7WGADcYvP5z9oiL8HM48FxtE1W53f3bgdMqbnZjfLyCOjAHYk
  priority: 102
  providerName: ProQuest
Title Epidemiology of atrial fibrillation: European perspective
URI https://www.ncbi.nlm.nih.gov/pubmed/24966695
https://www.proquest.com/docview/2224438541
https://www.proquest.com/docview/1541383505
https://pubmed.ncbi.nlm.nih.gov/PMC4064952
https://doaj.org/article/9e1fbff394134463934fbf2f5e5b48cc
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1ta9RAEB768kUQ8d1oPSMUBCF1k93bZAWR9rhyiJaiHtRPy2azq8KRq9cr2H_vTDZJL1q_HFx2ctxMZjLPLLPPAOyL3BEPmMUixxaJUGWZGFvxpJK5U8bxPA_dFidyNhcfzsZnW9AN42wNeHFjaUfzpOarxcHvX1fvMeDfURtzKvI3k4_T04MvgnhZtmEXU1JOEfqpxfnNK5ljmmwGxxEDWkKUfOGs3t_3EzewwApA0ryJjUTV8Pn_-9beSFvDlsqNHHV8F-604DI-DN5wD7ZcfR9uh525OBw4egBqej0U9ipe-tg0kztiT83_i9Aa9zbudunj8-vTmA9hfjz9Opkl7QCFxI6lWic2YybNmSJWP-G9x9KHGbyCRQovROZUxfCZVFgFl0VWqkw6Zp1hwmQImkzl-SPYqZe1ewJxxbzhUpaVtFxYjFtfGEfo0BiZpaWM4HVnLW1bdnEacrHQWGWQlTVZWQcrR7DfC58HUo2bxY7I7L0IMWE3F5ar77oNLK1c6kvvucJsjKUtR2Xxe-bHblyKwtoIXtBD0-FYaR_P-lAQ3ONSpRG8aiTIx_AvW9MeTEDFiRtrILk3kMRItMPlzjF058ga8ZcQqIzA5Zf9Mt1J3W21W15eaISxKUcozFDlx8GPeqU7d4wgH3jYwCrDlfrnj4YnHLEalr_Z0__-5jO4hfhPhB2lPdhZry7dc8RY63IE2-zbDD-LSTqC3aPpyennUbNfMWoi6w9znyRa
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-N7gGkCfG9wGBBGkJCypbYjhMjIbSNTh0r1QSbtDfjODYgTU1ZO6H9U_yNnOMkXQTibY-Nr5V9Od_d73ofAFssM64PmEaQo_OIiaKIlC5pVPLMCGVolvlsiwkfnbKPZ-nZCvxua2FcWmWrE2tFXVbaxch30I4xRvOUJe9nPyM3Ncr9u9qO0PBicWSufiFkm787_IDv9xUhB8OT_VHUTBWIdMrFItIkVkmGQJ6xjFlrEQ_ECp-g505zRowoY9xoidCwyEkhCDexNipmiqAnoUpL8XdvwSqjCGUGsLo3nBx_7qI6MUV7nMW-ENCNANrZHw-Pt78w1zSmZ_rqCQF_24FrhrCfpHnN6h3cg7uNuxruevm6Dytm-gDWfKwv9CVMD0EMl2Nmr8LKhqqeBRJaV05w7pPt3oZt3D-cLes7H8HpjTDvMQym1dSsQ1jGVlHOi5JryjRqApsr4_xNpThJCh7Am5ZbUjf9yt3YjHOJuMWxVjrWSs_aALY64plv0_Fvsj3H9o7E9dauH1QX32RzVaUwiS2spQLtO4JliofFz8SmJi1YrnUAm-6lSV-o2mkIucucA0m5SAJ4XVM4HYFb1qopdcCDu25bPcqNHiXebd1fbgVDNrplLpc3IYCX3bL7psuXm5rqci7RMU4oOtcxHvmJl6Pu0Ai4EbMKXMl6EtbjSn9l-uN73XkcvT8E1OTp_7e1CbdHJ5_Gcnw4OXoGd9DFZD5otQGDxcWleY5u3KJ40dydEL7e9HX9Az-KWSg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9RAEB5qBRFEfPe02ggVQYiXZDebrCBSr3e0tpSCFvptu9nsqlCSs3dF-tf8dc5kk1yD4rd-THYSdic7L89mXgC2eGapDphBkGPykMuiCLUpWViKzEptWZb5aItDsXvMP5-kJ2vwu8uFobDKTic2irqsDZ2Rj9GOcc7ylMdj14ZFHO3MPs5_htRBiv60du00_BbZt5e_EL4tPuzt4Ld-nSSz6dfJbth2GAhNKuQyNEmk4wxBPecZd84hNog03kEvnuU8sbKMcNIlwsQiTwqZCBsZqyOuE_QqdOkYvvcG3MwY2lnKUp_E_flOxNAyZ5FPCaRmQOPJwfTo3RdO5WMGRrDpFfC3RbhiEofhmlfs3-we3G0d12Db77T7sGarB3DHn_oFPpnpIcjpquHsZVC7QDddQQJHiQVnPuzufdD9AQjmq0zPR3B8Lax7DOtVXdmnEJSR00yIohSGcYM6weXakueptUjiQozgbcctZdrK5dRA40whgiHWKmKt8qwdwVZPPPcFO_5N9onY3pNQle3mRn3-TbVCq6SNXeEck2jpETYzXCxeJy61acFzY0awSR9N-ZTVXleobU6uJBMyHsGbhoK0BU7Z6DbpARdOdbcGlBsDSpRyMxzuNoZqtcxCrWRiBK_6YXqSIucqW18sFLrIMUM3O8IlP_H7qF80Qm9ErxJHssEOG3BlOFL9-N7UIEc_EKF18uz_09qEWyik6mDvcP853EZfk_vTqw1YX55f2Bfozy2Ll43gBHB63ZL6BzoxW8w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+atrial+fibrillation%3A+European+perspective&rft.jtitle=Clinical+epidemiology&rft.au=Zoni-Berisso%2C+Massimo&rft.au=Lercari%2C+Fabrizio&rft.au=Carazza%2C+Tiziana&rft.au=Domenicucci%2C+Stefano&rft.date=2014-01-01&rft.issn=1179-1349&rft.eissn=1179-1349&rft.volume=6&rft.spage=213&rft_id=info:doi/10.2147%2FCLEP.S47385&rft_id=info%3Apmid%2F24966695&rft.externalDocID=24966695
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1179-1349&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1179-1349&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1179-1349&client=summon